Microbiological Testing for Herbal Powders: What USP <61> and <62> Require — and Where Raw Materials Fail Most Often

Herbal powders fail incoming microbial testing more often than any other ingredient category we process. That’s not an impression — it’s what our raw material submission data shows, batch after batch, season after season. Root powders especially: ashwagandha, turmeric, valerian, maca. Spray-dried botanical extracts from overseas contract manufacturers. Ground bark. Seed powders that have been bagged, warehoused, and shipped across two continents before they reach a Midwest formulator’s receiving dock.

The reason isn’t surprising once you understand the biology. But the number of brands that release these materials into production without running USP <61> and <62> still is.

Why Herbal Powders Are Uniquely High-Risk for Microbial Contamination

Botanical raw materials start their lives in soil. That matters because soil is a rich reservoir for aerobic spore-formers — Bacillus cereus, Clostridium species, Aspergillus molds — organisms that survive drying, bagging, and even mild heat treatments. Root powders are harvested in contact with that soil, dried (sometimes in open-air facilities with inconsistent temperature and humidity controls), milled, and packed. Each step is a contamination opportunity.

Water activity plays a role, but not always the protective one buyers assume. A turmeric root powder sitting at 0.55 Aw is dry enough to resist active mold growth in storage — but the spores and bacteria that colonized it during harvest and drying are already locked into the count. You’re not growing new contamination in the bag; you’re packaging what was already there.

In our experience, these categories fail most consistently:

• Root powders (ashwagandha, valerian, burdock, marshmallow root): routinely high total aerobic microbial counts, sometimes exceeding 10⁶ CFU/g on receipt
• Unsterilized mushroom powders (reishi, lion’s mane, chaga): elevated total yeast and mold counts, occasional Aspergillus detection
• Bulk spray-dried botanical extracts from Asia: highly variable — some suppliers run in-house steam sterilization or gamma treatment, many don’t, and the CoA often doesn’t indicate which

Compare those to a synthetic mineral like magnesium glycinate or zinc bisglycinate: near-zero microbial concern in almost every lot we’ve seen. Herbal is a categorically different world, and treating all raw materials the same way is how microbial problems reach finished products.

What USP <61> and <62> Actually Measure

USP <61> (Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests) establishes the plate-count methodology used to determine the total aerobic microbial count (TAMC) and the total combined yeast and mold count (TYMC). These are your quantitative results — reported in CFU per gram of sample.

USP <62> (Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms) covers the qualitative presence/absence screens for:

• Salmonella spp. (tested in 10 g of sample)
• Escherichia coli (1 g)
• Staphylococcus aureus (1 g)
• Pseudomonas aeruginosa (1 g)
• Candida albicans (1 g)
• Bile-tolerant gram-negative bacteria (quantitative, reported in CFU/g)

Taken together, these two chapters give a reasonably complete microbial profile of a botanical ingredient. The acceptance criteria themselves live in USP <2023> — and the specific category you’re in determines everything.

For Category 4B (oral herbal medicinal products prepared without boiling water — which covers virtually all encapsulated, tableted, and powdered supplement formats), the limits are:

• TAMC: ≤ 10⁵ CFU/g
• TYMC: ≤ 10⁴ CFU/g
• Bile-tolerant gram-negative bacteria: ≤ 10³ CFU/g
• E. coli: absent in 1 g
• Salmonella: absent in 25 g

That TAMC ceiling of 10⁵ CFU/g is where a substantial share of unsterilized root powders fail. An ashwagandha lot with a count of 3 × 10⁶ CFU/g — which is not uncommon — exceeds the limit by 30-fold. It might have passed on the supplier’s in-house CoA if their lab ran a less sensitive method or skipped the method suitability validation step entirely. It won’t pass once an accredited analytical testing laboratory runs the compendial procedure.

The Subtlety Most Brands Miss: Antimicrobial Botanicals and Method Suitability

Here’s something that doesn’t appear in most supplier FAQs but is one of the most consequential technical variables in botanical microbiology: many herbal powders and extracts have intrinsic antimicrobial activity. Oregano, thyme, rosemary, garlic, clove, cinnamon, and dozens of essential-oil-rich botanicals can actively inhibit the growth of target organisms in the agar media itself. The result is a falsely low plate count — not because the sample is clean, but because the extract killed the organisms on the plate.

USP <61> explicitly requires analysts to validate their test for each matrix through a method suitability experiment: a known quantity of challenge organisms — typically 10–100 CFU each of Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus subtilis, Candida albicans, and Aspergillus brasiliensis — is spiked into the prepared sample, and the analyst must demonstrate recovery of at least 50% of the inoculum. If recovery falls below 50%, the method is failing and must be modified before reporting any results.

Common modifications include additional dilution steps to reduce the antimicrobial concentration, addition of chemical neutralizers (Tween 80, lecithin, histidine, or sodium thiosulfate depending on the matrix), or switching to membrane filtration to physically separate organisms from the extract prior to plating.

We run method suitability on every novel matrix — any botanical we haven’t established a validated protocol for. For brands submitting an unusual extract, that step adds time upfront. But it’s the only way to be confident that the number on the CoA reflects reality rather than the extract doing the cleanup for you.

How Analytical Testing Laboratories Structure a Full USP <61>/<62> Panel

At a practical level, here’s what a complete microbial panel looks like when a herbal powder arrives at our Countryside, IL receiving facility and is sent to our ISO 17025-accredited testing partners:

1. Sample intake and preparation: A 10 g analytical portion is weighed in a BSL-2 controlled environment. The sample is homogenized in 90 mL of pH 7.0 phosphate-buffered saline (or an equivalent USP-compliant diluent) using a validated stomacher or equivalent homogenizer at 230 rpm for 60 seconds.

2. Method suitability (new matrices): Challenge organisms are prepared at the target inoculation level and recovery is confirmed to meet the ≥ 50% threshold before proceeding with sample analysis.

3. TAMC enumeration: Serial dilutions are plated on Tryptic Soy Agar using the pour-plate or surface-spread method and incubated at 30–35°C for 3–5 days. All colonies are counted at the dilution yielding 30–300 CFU per plate.

4. TYMC enumeration: Parallel dilutions are plated on Sabouraud Dextrose Agar (with antibiotics to suppress bacteria) and incubated at 20–25°C for 5–7 days. Counts are reported separately from TAMC.

5. Specified organism screens (<62>): Enrichment broth steps are followed by selective plating and, where required, biochemical or immunoassay confirmation for each specified organism. Salmonella typically requires 24–48 hours of pre-enrichment in buffered peptone water before transfer to selective media.

6. Result calculation and reporting: Colony counts at the appropriate dilution factor are back-calculated to CFU/g. Values below the validated detection limit are reported as < [detection limit] CFU/g rather than zero.

Total turnaround from sample receipt to a signed CoA runs 7–10 business days under standard protocols. The TYMC plates pace the timeline — the 5–7 day incubation at 20–25°C can’t be shortened without compromising slow-growing molds that USP expects the method to capture.

One clarification worth making: a USP <61>/<62> panel does not include mycotoxin screening (aflatoxins B1, B2, G1, G2; ochratoxin A), pesticide residues, or botanical identity confirmation. Microbial testing is one component of a complete incoming raw material release protocol. Under 21 CFR 111.75(a), your written procedures should specify which tests are required before any ingredient is approved for use in a dietary supplement — and for most botanical raw materials, that list is longer than microbials alone.

What a Failure Actually Means — and Your Options

A TAMC of 3 × 10⁶ CFU/g on an ashwagandha lot is a failure against the USP <2023> Category 4B limit of 10⁵ CFU/g. But it isn’t automatically a rejection if you have remediation options and documented procedures in your quality system.

Gamma irradiation is the most widely used remediation method for botanical powders in the US dietary supplement industry. At doses between 5 kGy and 25 kGy, it achieves multi-log reductions in both TAMC and TYMC without significantly degrading most bioactive compounds or sensory properties. Many contract manufacturers source pre-irradiated botanicals by default precisely to avoid this issue at receiving. If your supplier can’t certify that materials were irradiated — or if they can’t tell you what dose was applied — that’s a supplier qualification conversation worth having now, not after a failed lot.

Ethylene oxide (EtO) treatment is technically effective but increasingly problematic from a regulatory and market standpoint. California’s OEHHA classifies EtO as a known human carcinogen, and residue limits under California law are stringent enough to create compliance risk for products sold in-state. Brands with national distribution are largely moving away from EtO-treated ingredients.

Post-remediation re-testing: Any lot that undergoes a microbial reduction step must be re-tested to the same USP <61>/<62> specification before release. The post-treatment CoA is what belongs in your batch manufacturing record — not the pre-treatment result.

If the <62> screens return positive for Salmonella in any portion of the sample, remediation isn’t the right path. That’s a rejection, supplier notification, and a root-cause inquiry. A Salmonella-positive raw material that enters your facility is a finished-product recall waiting to happen.

The simplest operating rule for Chicago-area and Midwest brands sourcing botanical ingredients: don’t assume a dry powder is microbiologically safe, and don’t assume an overseas supplier’s in-house CoA was run to USP compendial standards with proper method suitability validation. An independent result from an accredited analytical testing laboratory, returned in under 10 business days, costs a fraction of the FSMA notification, product destruction, and reputational fallout from a contaminated finished product.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days Contact us

Related from our network

• ISO 17025-Accredited Supplement Ingredient Testing at Qalitex Laboratories — Full incoming raw material release panels (microbiology, heavy metals, identity, potency) with same-day sample receiving in California and Illinois.